The role of SMARCB1/INI1 in development of rhabdoid tumor

被引:154
作者
Roberts, Charles W. M. [3 ]
Biegel, Jaclyn A. [1 ,2 ]
机构
[1] Childrens Hosp Philadelphia, Dept Pediat, Div Human Genet, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
[3] Harvard Univ, Childrens Hosp, Dept Pediat Oncol, Dana Farber Canc Inst,Sch Med,Div Hematol Oncol, Boston, MA 02115 USA
关键词
rhabdoid tumor; retroperitoneum; angiogenesis; surgery; chemotherapy; radiotherapy; targeted therapy; recurrence; metastasis; CHROMATIN-REMODELING COMPLEX; ATYPICAL TERATOID/RHABDOID TUMORS; STRAND BREAK REPAIR; CELL-CYCLE ARREST; DNA-DAMAGE; SUPPRESSOR GENE; HSNF5/INI1; GENE; IMMUNOHISTOCHEMICAL ANALYSIS; MOLECULAR CHARACTERIZATION; FAMILIAL SCHWANNOMATOSIS;
D O I
10.4161/cbt.8.5.8019
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A note about nomenclature: The ortholog of the gene mutated in rhabdoid tumors was first studied in yeast where it was identified in a screen for mutants incapable of fermenting sucrose. It was thus given the name Sucrose Non-Fermenting gene number 5 (SNF5) and was subsequently found to be a member of the SWI/SNF chromatin remodeling complex. The human ortholog of the gene was identified in a screen for proteins capable of interacting with the integrase protein of the human immunodeficiency virus and was given the name INtegrase Interactor 1 (INI1). Investigators studying a mammalian version of the Swi/Snf complex felt that its function may have diverged somewhat from the yeast complex and thus proposed renaming the complex the Brg1/Brm Associated Factors complex, or BAF complex. The rhabdoid tumor gene was thus given the name BAF47 based upon its apparent molecular mass of 47 Kd. Most recently, the genetic nomenclature committee bestowed the name SMARCB1 for SWI/SNF related, Matrix associated, Actin dependent Regulator of Chromatin, subfamily B, member 1. Each of these names has been used extensively in the literature and we ourselves have referred to the gene as either SNF5 (CWMR) or INI1 (JAB). In an effort to simplify communication, we have chosen to use the official SMARCB1 nomenclature here.
引用
收藏
页码:412 / 416
页数:5
相关论文
共 65 条
[1]   Targeting cyclin D1, a downstream effector of INI1/hSNF5, in rhabdoid tumors [J].
Alarcon-Vargas, D ;
Zhang, Z ;
Agarwal, B ;
Challagulla, K ;
Mani, S ;
Kalpana, GV .
ONCOGENE, 2006, 25 (05) :722-734
[2]   Re-expression of hSNF5/INI1/BAF47 in pediatric tumor cells leads to G1 arrest associated with induction of p16ink4a and activation of RB [J].
Betz, BL ;
Strobeck, MW ;
Reisman, DN ;
Knudsen, ES ;
Weissman, BE .
ONCOGENE, 2002, 21 (34) :5193-5203
[3]   MONOSOMY-22 IN RHABDOID OR ATYPICAL TUMORS OF THE BRAIN [J].
BIEGEL, JA ;
RORKE, LB ;
PACKER, RJ ;
EMANUEL, BS .
JOURNAL OF NEUROSURGERY, 1990, 73 (05) :710-714
[4]  
Biegel JA, 2002, CLIN CANCER RES, V8, P3461
[5]  
Biegel JA, 1999, CANCER RES, V59, P74
[6]   hSNFS/INII-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities [J].
Bourdeaut, F. ;
Freneaux, P. ;
Thuille, B. ;
Lellouch-Tubiana, A. ;
Nicolas, A. ;
Couturier, J. ;
Pierron, G. ;
Sainte-Rose, C. ;
Bergeron, C. ;
Bouvier, R. ;
Rialland, X. ;
Laurence, V. ;
Michon, J. ;
Sastre-Garau, X. ;
Delattre, O. .
JOURNAL OF PATHOLOGY, 2007, 211 (03) :323-330
[7]   Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis [J].
Boyd, C. ;
Smith, M. J. ;
Kluwe, L. ;
Balogh, A. ;
MacCollin, M. ;
Plotkin, S. R. .
CLINICAL GENETICS, 2008, 74 (04) :358-366
[8]   RhoA-Dependent regulation of cell migration by the tumor suppressor hSNF5/INI1 [J].
Caramel, Julie ;
Quignon, Frederique ;
Delattre, Olivier .
CANCER RESEARCH, 2008, 68 (15) :6154-6161
[9]   Distinct roles for the RSC and Swi/Snf ATP-dependent chromatin remodelers in DNA double-strand break repair [J].
Chai, B ;
Huang, J ;
Cairns, BR ;
Laurent, BC .
GENES & DEVELOPMENT, 2005, 19 (14) :1656-1661
[10]   Loss of the hSNF5 gene concomitantly inactivates p21CIP/WAF1 and p16INK4a activity associated with replicative senescence in A204 rhabdoid tumor cells [J].
Chai, JJ ;
Charboneau, AL ;
Betz, BL ;
Weissman, BE .
CANCER RESEARCH, 2005, 65 (22) :10192-10198